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ABSTRACT
Aim: Continuous pain occurs routinely, even after invasive procedures, or inflammation and surgery, but
clinical practices associated with assessments of continuous pain remain unknown.
Methods: A prospective cohort study in 243 neonatal intensive care units (NICUs) from 18 European
countries recorded the frequency of pain assessments, use of mechanical ventilation, sedation,
analgesia or neuromuscular blockade for each neonate for up to 28 days after NICU admission.
Results: Only 2113 of 6648 (31.8%) of neonates received assessments of continuous pain,
occurring variably among tracheal ventilation (TrV, 46.0%), noninvasive ventilation (NiV, 35.0%) and
no ventilation (NoV, 20.1%) groups (p < 0.001). Daily assessments for continuous pain occurred in
only 10.4% of all neonates (TrV: 14.0%, NiV: 10.7%, NoV: 7.6%; p < 0.001). More frequent
assessments of continuous pain occurred in NICUs with pain guidelines, nursing champions and
surgical admissions (all p < 0.01), and for newborns <32 weeks gestational age, those requiring
ventilation, or opioids, sedatives-hypnotics, general anaesthetics (O–SH–GA) (all p < 0.001), or
surgery (p = 0.028). Use of O–SH–GA drugs increased the odds for pain assessment in the TrV
(OR:1.60, p < 0.001) and NiV groups (OR:1.40, p < 0.001).
Conclusion: Assessments of continuous pain occurred in less than one-third of NICU admissions and
daily in only 10% of neonates. NICU clinical practices should consider including routine assessments of
continuous pain in newborns.
Abbreviations
C.I., Confidence intervals; CRIB, Clinical Risk Index for Babies; EDIN, Echelle Douleur Inconfort Nouveau-ne; EUROPAIN, European-
pain-audit-in-neonates; GEE, Generalised estimating equations; IQR, Interquartile range; IUGR, Intrauterine growth retardation; NA,
Not applicable; NICUs, Neonatal intensive care units; NiV, Noninvasive ventilation; NoV, No ventilation, that is breathing spontaneously;
N-PASS, Neonatal Pain, Agitation and Sedation Scale; NPIs, National Principal Investigators; OR, Odds ratio; O-SH-GA, Opioids,
sedative hypnotics or general anaesthetics; PCA, Postconceptual age; QIC, Quasi-likelihood under the Independence model Criterion;
SD, Standard deviation; STROBE, Strengthening the reporting of observational studies in epidemiology; TrV, Tracheal ventilation.
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INTRODUCTION
All newborns experience acute episodic pain or prolonged,
continuous pain during admission to neonatal intensive
care units (NICUs) (1,2). Untreated neonatal pain prolongs
human suffering and is often associated with short-term and
long-term physical, behavioural, or cognitive sequelae (3,4).
Conversely, some analgesic drugs can prolong mechanical
ventilation (5), delay feedings (6) or impair brain growth
and development (7–9). Pain needs to be assessed before
treatment, but neonatal pain assessments are time- and
labour-intensive and difficult to implement in routine NICU
care (10–12).
Bedside nurses make global pain assessments or apply
validated pain assessment tools before treating a newborn’s
pain or discomfort (13,14), but NICU workloads may not
allow bedside nurses to assess pain regularly. Most neonatal
pain scales were designed to measure acute pain from skin-
breaking procedures; these scales may not be clinically
relevant for measuring continuous pain (15). Assessments
of the continuous pain that follows invasive procedures, or
inflammation and surgery, may enhance the quality of pain
management, avoid untreated pain vs. unnecessary analge-
sia, prevent under- or overdosing of analgesics, or develop-
ment of drug tolerance (16–18).
Continuous pain may be defined as pain lasting beyond
the initial episode that causes tissue injury (19), mucosal
stimulation (20) or inflammation (4,21). Attempts to define
chronic or continuous pain in newborns have not led to
consistent or clinically useful definitions (16,17). Identify-
ing continuous pain is important because it may interfere
with infant growth, prolong hospitalisation, alter subse-
quent pain perception and impair cognitive and beha-
vioural development (4,17). Few methods, however, were
designed to assess continuous pain (15,22–24) and the
application of assessment methods designed using acute
pain models to clinical assessments of continuous pain
remains controversial (25).
We hypothesized that continuous pain is not assessed
routinely during NICU care, but may be assessed more
frequently among neonates receiving mechanical ventila-
tion than in neonates breathing spontaneously. Our objec-
tives were to study the frequency of bedside assessments for
continuous pain as well as the individual and institutional
factors determining the use of these assessments in routine
NICU care. We report assessments of continuous pain in
6648 neonates studied in 243 NICUs from 18 European
countries.
METHODS
Study design
European-pain-audit-in-neonates (EUROPAIN) was a
prospective observational study of clinical practices related
to sedation/analgesia and was designed using STROBE
guidelines (26). The website (www.europainsurvey.eu)
stored multilingual study materials, instructive videos on
completing online questionnaires, documents, progress
reports and the complete study protocol (http://www.
europainsurvey.eu/europain-survey-protocol/). Website links
connected authorised users to secure servers (hosted by
Voozanoo; Epiconcept, Paris, France) for data entry into
standardised questionnaires.
Participating centres
NICU nurses or physicians volunteered as National Prin-
cipal Investigators (NPIs); each NPI invited participation of
all NICUs in their country and provided data on national
pain guidelines for neonates. Level III NICUs initiating and
performing the full period of mechanical ventilation were
eligible for participation; NICUs unable to provide the full
range of Level III care were not eligible. A study nurse, data
quality manager and physician coordinator were appointed
for each unit, providing information on NICU characteris-
tics and local sedation/analgesia protocols. NICUs were
queried about the presence of nurses or physicians with
specialised knowledge and/or commitment to neonatal
pain management; these clinicians were labelled as physi-
cian or nurse pain champions.
Data collection
During prespecified enrolment periods, all NICU admis-
sions up to 44 weeks postconceptual age were included.
Demographic data, modes of ventilation, use of continuous
or intermittent sedation/analgesia or neuromuscular block-
ers, and assessments of continuous pain for each neonate
were collected prospectively during the first 28 days of
NICU admission, or until death, or hospital discharge.
NICUs were specifically asked to record pain assessments
performed with pain tools designed for measuring pro-
longed, continuous pain; two examples of these scales were
given on the data collection sheets [e.g. Echelle Douleur
Inconfort Nouveau-ne (EDIN) scale, COMFORT scale]
and NICU staff could record any other pain scales they used
for continuous pain. Data collection occurred for one
month in all participating NICUs; enrolment periods were
staggered such that less than forty (40) NICUs enrolled
Key notes
 Neonatal pain assessments have previously focused on acute pain associated with skin-breaking procedures, but the
importance of assessing continuous pain remains unknown.
 Assessments of continuous pain varied 0–100% in neonatal intensive care units (NICUs), occurring daily in 10.4% of all
neonates and at least once during their NICU stay in 31.8% neonates.
 Neonatal pain research, clinical guidelines and bedside practices should also focus on assessments of continuous pain in
addition to the assessments for procedural pain.
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patients concomitantly, allowing the coordinating centre to
closely monitor data collection at each site. Subject
recruitment was authenticated via the NICU admissions
logbook. As the study focus was continuous pain (not
procedural pain), we specifically collected data on pain
assessments carried out with continuous pain tools,
recorded which assessment tools were used, and the
number of assessments per day. Newborns were included
in the pain-assessed group if at least one assessment of
continuous pain occurred during their entire NICU stay.
NICUs were included in the pain-assessed group if any
assessments of continuous pain were recorded from
that unit.
Data quality assurance
A centralised team in Paris monitored completeness and
relevance of the data collection. Missing or incongruous
data were reported to unit coordinators and locally double-
checked. The monitoring team randomly selected 10% of
subjects (minimum five patients) and the local data quality
manager completely double-checked all these patients. If
1% or more errors occurred, data from another 10%
subjects were double-checked; if 1% error rates persisted,
all data entries from that NICU were double-checked.
Regulatory compliance
Study protocols and data collection were first approved by
the regulatory bodies for Protection of Human Subjects,
Data Protection, and Health Research Data Management in
France and then approved by similar committees in each
country and at some participating sites. Information sheets
were given to parents to explain the de-identified data
collection, and they were free to decline their child’s
participation. In some countries (e.g. Norway), parents
were required to give consent for participation. The study
was registered at ClinicalTrials.gov (#NCT01694745).
Sample size
Sample size calculations were based on sedation/analgesia
practices (27). We anticipated the participation of at least
15 countries and planned to make comparisons between all
countries. We used a chi-square power analysis to calculate
the sample size. We expected small differences in sedation
or analgesia practices between countries, estimating an
effect size (W) of 0.1 for calculations. NCSS-PASS
(version 2008; Kaysville, UT, USA) showed that a sample
size of 2303 neonates would achieve 90% power to detect
an effect size of 0.1 with 14 degrees of freedom (15 centres),
using a chi-square test with an a-error of 0.05. Estimating a
small effect size and requiring 90% power ensured adequate
sample size, thus minimising b-error.
Data analyses
Data analyses used SPSS v17 (Chicago, IL, USA) for
descriptive and multivariable analyses. We used a gener-
alised estimating equation (GEE) multivariable model (28)
with country or site as the clustering unit. In all neonates,
and separately, in ventilated neonates, the clinical factors
correlated with NICU pain assessments (p ≤ 0.05) were
included in GEE models. The GEE model fit was assessed
by the quasi-likelihood under the independence model
criterion (QIC) (29). Results of GEE models are presented
as point-estimate odds ratios (OR) with two-sided 95%
confidence intervals (C.I.). To assess associations between
pain assessments and use of opioids, sedative hypnotics or
general anaesthetics (O–SH–GA), we analysed data from
patient-days with or without O–SH–GA using Mantel–
Haenszel chi-square tests, where modes of ventilation (TrV,
NiV) by day were the strata. Two-tailed p-values of 0.05 or
less were deemed significant.
RESULTS
Study population
From October 1, 2012, to June 30, 2013, we enrolled 6648
neonates eligible for this study (Fig. 1). Highest levels of
ventilation during the study period classified patients into
tracheal ventilation (TrV, n = 2138), noninvasive ventila-
tion (NiV, n = 1493) and spontaneous ventilation groups
(NoV, n = 3017); patient characteristics are listed in
Table 1 and their distribution among participating coun-
tries is listed in Table S1 (Supporting Information). Guide-
lines for neonatal pain management were available from six
countries (33%) and locally, from 182 NICUs (75%). The
mean (S.D.) period of study participation was 11.9 (9.7)
calendar days. Using data from 78 740 patient-days of
observation, units reported continuous pain assessment in
2838 neonates. Further detailed analyses showed that 725
neonates had pain assessed only using procedural pain tools
and were thus excluded from this analysis.
Clinical practices
Only 2113 of 6648 neonates (31.8%) received assessments
of continuous pain at least once during their NICU stay,
with 2 (1–4) (median [IQR]) pain assessments per day
(Table 2). Continuous pain assessments occurred in the
NICU for 984 of 2138 (46.0%) newborns in the TrV, 523 of
1493 (35.0%) NiV and 606 of 3017 (20.1%) NoV groups
(p < 0.001) (Table 1). To correct for the variable numbers
of subjects enrolled from each country, we weighted the
pain assessment rates by the number of enrolled newborns
per 10 000 births in that country (Table S1). The weighted
pain assessment rates were 36.0% for all infants, 46.6% for
TrV, 41.6% for NiV and 22.3% for NoV groups, showing
substantially similar findings.
Daily pain assessments occurred only in 10.4% (689/
6648) patients, including 14% TrV patients (300/2138),
10.7% NiV patients (160/1493) and 7.6% NoV patients
(229/3017; p < 0.001). Assessments of continuous pain
occurred commonly in French (100%), Dutch (80%) or
Belgian (75%) NICUs, but did not occur in five countries.
Across participating countries, pain assessments for con-
tinuous pain ranged from 6% to 90% in the TrV group, from
0% to 87% in the NiV group and from 0% to 84% in the
NoV group (Table 2). On average, individual newborns
received 0.8 to 6.7 pain assessments per day (Table 2).
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Moreover, many different tools were used to assess contin-
uous pain; the EDIN scale was used most frequently (1199/
2113, 56.7%); other scores used commonly included the
COMFORTneo behaviour scale (19.7%), the N-PASS
(Neonatal Pain, Agitation and Sedation Scale; 13.2%),
and the COMFORT scale (10.1%) (Table S2).
NICU characteristics
NICU characteristics increasing the assessment of contin-
uous pain included the availability of local guidelines,
physician or nurse champions, pain consult services, num-
ber of surgical admissions and ventilator-days per year
(univariable analyses; Table 3). Multivariable GEE models
using country as a cluster showed that local pain assessment
guidelines (OR: 3.96), nurse pain champions (OR: 2.54) and
surgical admissions (OR: 1.01) prompted greater use of
continuous pain assessments (all p < 0.01).
Newborn characteristics
In univariable analyses, patient characteristics influencing
pain assessments in all neonates were as follows: gestational
age, birthweight, outborn status, age at admission, Clinical
Risk Index for Babies scores (CRIB), one-minute and five-
minute Apgar scores, intubation at admission, surgical
condition, respiratory distress syndrome, ventilation status,
use of O–SH–GA drugs and hospital length of stay
(Table 4). Multivariable modelling using NICUs as cluster
showed higher odds of pain assessments associated with
prematurity (24–29 weeks OR: 1.92; 30–32 weeks OR:
2.11, both p < 0.001), intubation at admission (OR: 1.97,
p < 0.001), need for surgery (OR: 2.14, p = 0.028), nonin-
vasive ventilation (OR: 1.88, p < 0.001) and use of O-SH-
GA drugs (OR: 1.99, p < 0.001), but lower odds with inborn
status (OR: 0.67, p = 0.023) and higher CRIB scores (OR:
0.95, p = 0.013) (Table 4). More frequent pain assessments
occurred specifically on those patient-days associated with
TrV (42.3% vs. 25.5%, p < 0.001) or the use of O-SH-GA
drugs (45.6% vs. 26.4%, p < 0.001) (Fig. 2).
Among tracheally ventilated newborns, patient character-
istics influencing continuous pain assessments in univariable
analyses included outborn status, CRIB scores, five-minute
Apgar scores, intubation at admission, surgical condition,
respiratory distress syndrome, use of O-SH-GA and duration
of mechanical ventilation. Multivariable GEE modelling
showed that the odds of pain assessments increased with
intubation at admission (OR: 2.00, p < 0.001) and O-SH-GA
use (OR: 1.45, p = 0.008), but decreased with higher CRIB
scores (OR: 0.93, p = 0.001) (Table 5).
31  
countries 
invited 
18 
countries  
participated 
No contact established or coordination failed:  
Bulgaria, Czech Republic, Iceland, Ireland, 
 Slovenia, Turkey, Denmark, Hungary, Latvia, 
 Luxembourg, Romania, Slovakia, 
Switzerland   
243  
units participated 
7076  
eligible neonates 
6648 
included neonates 
(94.0% enrollment rate) 
396 neonates were not included: 
141 no parental consent 
76 parents opted-out 
54 neonates were transferred 
11 died before inclusion 
15 parental linguistic barrier 
21 files were lost 
8 wrongly included 
3 missing data 
3 withdrawal for social problems 
64 reason not declared 
399 eligible units that 
did not participate 
32 missing data 
on the outcome 
“pain assessment” 
Figure 1 Flow chart of the countries invited, the participating NICUs (‘units’), patients assessed and those enrolled in this study. All neonates with pain assessment
outcome data were included in our analyses; missing data were not imputed.
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Are pain assessments associated with sedation/analgesia
in ventilated newborns?
In the TrV group, of the 1287 neonates who received
O-SH-GA drugs, 660 (51.3%) had at least one pain
assessment during their NICU stay. We analysed 33 625
patient-days in this group to test for associations between
assessments of continuous pain and the use of O-SH-GA
drugs. During TrV, pain assessment rates on patient-days
with and without O-SH-GA use were, respectively, 46.0%
vs. 34.7% (p < 0.001), with O-SH-GA use prompting 1.60-
fold greater odds of pain assessments (95% C.I. 1.48–1.73,
p < 0.001). When TrV group neonates were not receiving
mechanical ventilation, pain assessment rates on patient-
days with and without O-SH-GA use were, respectively,
41.7% vs. 24.7% (p < 0.001), showing 2.18-fold greater
odds of pain assessments (95% C.I. 1.91–2.48, p < 0.001)
with O-SH-GA use. In the TrV group, 1287 neonates who
received continuous O-SH-GA drugs; 518 (40.2%) had
pain assessments on the day of starting O-SH-GA and
another 100 (7.8%) had pain assessments on the day after
starting O-SH-GA drugs.
On analysing 21 130 patient-days in the NiV group, rates
of bedside pain assessments on patient-days with and
without O-SH-GA were, respectively, 36.8% vs. 29.9%
(p = 0.024) while receiving NiV, and 19.6% vs. 13.9% while
not receiving NiV (p = 0.092). The odds of continuous pain
assessments were 1.40-fold greater (95% C.I. 1.10–1.78) on
patient-days associated with O-SH-GA use.
DISCUSSION
Statement of principal findings
We report the first international, prospective observational
study investigating neonatal pain assessment practices in
European NICUs. Neonatal pain guidelines recommend
routine pain assessments scheduled every 4–6 hours each
day (30,31), but only 10% of neonates received daily
assessments of continuous pain. More than two-thirds of
all neonates and more than half of tracheally ventilated
neonates received no assessments of continuous pain
during their entire NICU stay! This reveals a significant
gap between recommended (30,31) and bedside practices
for neonatal pain assessment. Pain assessments varied from
0% to 100% across the three ventilation groups, the 243
NICUs, and the 18 countries; therefore, we identified the
individual and institutional characteristics associated with
pain assessments. We used GEE methods for multivariable
analyses to incorporate binary and continuous data,
weighted and nonweighted observations, as well as more
complex interactions between the variables in our database
(32). NICUs with local pain management guidelines,
nursing champions, and increased surgical admissions
Table 1 Baseline characteristics and rates of continuous pain assessment
Total
n = 6648
Tracheal ventilation
n = 2138
Noninvasive ventilation
n = 1493
Spontaneous ventilation
n = 3017 p Value*
Patient characteristics
Gestational age (weeks, mean  SD) 35.0  4.6 32.7  5.2 33.8  3.8 37.3  3.1 <0.001
24–29, number (%) 1045 (15.7) 775 (36.3) 214 (14.3) 56 (1.9) <0.001†
30–32, number (%) 1011 (15.2) 360 (16.8) 451 (30.2) 200 (6.6) –
33–36, number (%) 1853 (27.9) 389 (18.2) 486 (32.6) 978 (32.4) –
37–42, number (%) 2737 (41.2) 613 (28.7) 342 (22.9) 1782 (59.1) –
Birthweight (grams) Mean  SD 2385  1008 1950  1035 2133  892 2817  856 <0.001
Male, number (%) 3753 (56.5) 1257 (58.8) 841 (56.3) 1655 (54.9) 0.087
Inborn, number (%) 5340 (80.3) 1457 (68.1) 1306 (87.5) 2577 (85.4) <0.001
Type of delivery – number (%)
Vaginal 3051 (46.0) 877 (41.3) 569 (38.1) 1605 (53.3) <0.001
Caesarean 3577 (54.0) 1247 (58.7) 922 (61.8) 1408 (46.7) –
Age at admission (hr, median (IQR) 1.0 (0.3–12.1) 0.8 (0.3–8.3) 0.5 (0.2–1.7) 3.0 (0.4–26.8) <0.001
CRIB score‡ (median (IQR)) 0 (0–2) 2 (1–5) 0 (0–1) 0 (0–0) <0.001
Five-minute Apgar Score (mean  SD) 8.4  1.9 7.4  2.4 8.5  1.4 9.0  1.3 <0.001
Intubated at admission, number (%) 1372 (20.6) 1372 (64.2) NA NA NA
Died during study, number (%) 210 (3.2) 200 (9.4) 3 (0.2) 7 (0.2) <0.001
NICU length of stay (days)§ (median (IQR)) 8 (3–20) 14 (6–28) 11 (5–26) 5 (3–11) <0.001
Pain assessments, number (%)¶ 2113 (31.8) 984 (46.0) 523 (35.0) 606 (20.1) <0.001
NICU = Neonatal intensive care unit; NA = Not applicable; CRIB = Clinical Risk Index for Babies.
*Comparisons of the three types of ventilation were made with chi-square (Fisher’s exact test when required), ANOVA or Kruskal–Wallis test.
†Chi-square for distributions in all strata of gestational ages within the three ventilation groups.
‡The CRIB score is a measure of illness severity, based on clinical data from the first 12 hours after birth (range: 0–23, higher scores indicate great risk of
mortality).
§Data collection was stopped on day 28 of hospital stay; 1036 (15.6%) of 6647 neonates were hospitalised for longer than 28 days. Discharge data were
missing for one patient.
¶Only assessments carried out with continuous, ongoing pain scales were included.
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performed assessments of continuous pain more frequently.
Pain assessments also occurred more frequently among
newborns <32 weeks gestational age, those requiring
surgery, mechanical ventilation, use of opioids (morphine,
fentanyl, sufentanil), sedatives-hypnotics (midazolam, lor-
azepam, barbiturates) or general anaesthetics (ketamine,
propofol) in the NICU. Assessments of continuous pain in
ventilated neonates were more likely on the patient-days
associated with use of opioids, sedatives/hypnotics or
general anaesthetics (Fig. 2).
Strengths and weaknesses of this study
Assessments of continuous pain were associated with
greater severity of illness, because they occurred more
frequently in newborns with extreme prematurity, those
requiring intubation at admission, or surgical interventions,
or tracheal and noninvasive ventilation during their NICU
stay. Neonates with higher CRIB scores, however, had less
frequent pain assessments. This discrepancy may occur
because the CRIB score was designed to measure risk of
mortality from clinical factors at the time of NICU admis-
sion (33), and it does not reflect severity of illness during the
entire NICU stay.
Pain assessments occurred more frequently following use
of O-SH-GA drugs among all neonates, tracheally venti-
lated neonates and noninvasively ventilated neonates. Pain
assessments were also more likely on the patient-days when
these drugs were used (Fig. 2). Even among newborns
receiving continuous infusions of O-SH-GA drugs,
however, only 48% had assessments of continuous pain
on the same day or the day after starting these drugs. To
limit the data collection burden on participating NICUs, the
timing of pain assessments or drug administration was not
recorded; therefore, our data do not permit more detailed
analyses of the relationships between pain assessments and
therapeutic decision-making.
Another limitation could be that participating NICUs do
not represent national practices in each country. Because of
differences in the number of participating NICUs (and
subjects) across the different countries (Table S1), we
performed sensitivity analyses to weight the pain assess-
ment results with the proportion of neonates enrolled per
10 000 live births in each country. The results of these
analyses were substantially unchanged, thus suggesting
external validity for the European countries participating
in this study. While we acknowledge this limitation, other
than mandatory data collection (often with suspect data
quality), we had no practical options to overcome this
limitation. Level III NICUs with relatively high patient
volumes participated in all countries, not only representing
a snapshot of the most advanced practices in each country,
but also allowing us to sample on average about 0.15% of all
births per year (Table S1).
A putative ‘Hawthorne effect’ (34) could have altered pain
assessment practices during study enrolment, but this would
be difficult to maintain during 24/7 data collection over a
one-month period. Another limitation is that these results
were based on documentation of bedside pain assessments.
Table 2 Frequency of continuous pain assessments in participating countries and by ventilation group
Country
Centres performing
pain assessment*
Number (%)
Number of pain
assessments per
neonate per day†
Mean (SD)
Neonates with at least one pain assessment during NICU stay, number (%)
p Value‡
All neonates
n = 6648
Tracheal
ventilation
n = 2138
Noninvasive
ventilation
n = 1493
Spontaneous
ventilation
n = 3017
Austria 1/4 (25.0) 0.8 (0.7) 31/73 (42.5) 8/22 (36.4) 20/32 (62.5) 3/19 (15.8) 0.004
Belgium 3/4 (75.0) 1.3 (1.4) 29/128 (22.7) 16/37 (43.2) 9/51 (17.6) 4/40 (10.0) 0.001
Cyprus 0/1 (0.0) 0 0/84 (0.0) 0 0 0 –
Estonia 0/2 (0.0) 0 0/22 (0.0) 0 0 0 –
Finland 1/6 (16.7) 2.3 (0.8) 18/201 (9.0) 3/52 (5.8) 5/45 (11.1) 10/104 (9.6) 0.619
France 34/34 (100.0) 2.6 (1.8) 779/885 (88.0) 445/493 (90.3) 192/222 (86.5) 142/170 (83.5) 0.047
Germany 1/4 (25.0) 0.8 (0.8) 2/126 (1.6) 2/29 (6.9) 0/17 (0.0) 0/80 (0.0) 0.033
Greece 0/13 (0.0) 0 0/455 (0.0) 0 0 0 –
Italy 20/28 (71.4) 1.4 (1.4) 236/422 (55.9) 93/131 (71.0) 84/150 (56.0) 59/141 (41.8) <0.001
Lithuania 0/1 (0.0) 0 0/45 (0.0) 0 0 0 –
Malta 0/1 (0.0) 0 0/28 (0.0) 0 0 0 –
The Netherlands 4/5 (80.0) 1.6 (0.8) 166/208 (79.8) 56/69 (81.2) 55/68 (80.9) 55/71 (77.5) 0.832
Norway 3/16 (18.8) 1.1 (0.9) 29/334 (8.7) 3/35 (8.6) 7/94 (7.4) 19/205 (9.3) 0.874
Poland 2/8 (25.0) 2.7 (1.3) 30/83 (36.1) 11/50 (22.0) 14/25 (56.0) 5/8 (62.5) 0.004
Portugal 10/14 (71.4) 3.1 (2.6) 140/236 (59.3) 36/55 (65.5) 29/54 (53.7) 75/127 (59.1) 0.457
Spain 5/30 (16.7) 1.8 (1.3) 28/468 (6.0) 14/202 (6.9) 8/149 (5.4) 6/117 (5.1) 0.750
Sweden 2/6 (33.3) 6.7 (3.9) 27/160 (16.9) 21/38 (55.3) 4/47 (8.5) 2/75 (2.7) <0.001
United Kingdom 30/66 (45.5) 5.7 (6.0) 598/2690 (22.2) 276/713 (38.7) 96/438 (21.9) 226/1539 (14.7) <0.001
Total 116/243 (47.7) 3.3 (3.9) 2113/6648 (31.8) 984/2138 (46.0%) 523/1493 (35.0) 606/3017 (20.1) <0.001
*At least in one neonate.
†In neonates who had at least 1 assessment for continuous pain during their entire NICU stay.
‡Comparisons of three types of ventilation using chi-square tests.
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NICU nurses may rigorously record the use of pain medi-
cations, whereas pain assessments and nonpharmacological
interventions may be recorded less rigorously. Many NICUs
require the regular charting of bedside pain scores every 4–
6 hours with the patient’s vital signs. Data collection
occurred from any existing record, including patient notes,
nursing flowsheet at bedside or other sources. We believe
that all pain assessments occurring at the bedside were
recorded in our data collection.
Despite the aforementioned limitations, this is the largest
study to date, using prospective data collection, robust data
quality assurance, enrolling 94% of all eligible neonates,
accounting for all nonenrolled neonates, while overcoming
the language, cultural and research regulatory barriers in
18 countries. Thus, it represents the most comprehensive
glimpse into the current bedside pain assessment practices
in NICUs.
Strengths and weaknesses in relation to other studies
NICU nurses are primarily responsible for bedside pain
assessments in neonates although some have questioned
the utility (35) and validity (36) of these assessments. An
alternative approach calls for using pain scores for research
studies and pain detection for clinical care (37), but it still
does not address the need for assessing continuous pain.
Well-known weaknesses in the current paradigm for
neonatal pain assessments include their subjectivity, low
inter-rater reliability and other concerns (10,15,18,38–40).
Sedatives and neuromuscular blockers may also mask the
behavioural signs of continuous pain (27). Despite the
weaknesses and caveats of neonatal pain assessment tools,
we posit that routine assessments of continuous pain will
improve individualised pain management (18,41).
Of the currently available pain assessment tools, only
the EDIN (22), COMFORTneo (24), ALPS-Neo (Astrid
Table 3 NICU characteristics associated with assessments of continuous pain
All centres
Univariable analysis* Multivariable analysis†
No pain assessment
(n = 110)
n (%)‡
Pain assessment
(n = 93)
n (%)‡
Chi-square or
Mann–Whitney
U-test Odds ratio (95% CI) p Value
Local neonatal pain assessment guidelines in 2012
No (n = 80) 61 (76.3) 19 (23.8) <0.001 1§ <0.001
Yes (n = 123) 49 (39.8) 74 (60.2) 3.96 (2.11–7.46)
Local neonatal pain/sedation treatment guidelines in 2012
No (n = 50) 37 (74.0) 13 (26.0) 0.001 Not Included¶
Yes (n = 153) 73 (47.7) 80 (52.3)
Physician pain champion**
No (n = 127) 83 (65.4) 44 (34.6) <0.001 Not Included††
Yes (n = 76) 27 (35.5) 49 (64.5)
Nurse pain champion**
No (n = 107) 72 (67.3) 35 (32.7) <0.001 1§ 0.009
Yes (n = 96) 38 (39.6) 58 (60.4) 2.54 (1.27–5.11)
Hospital pain management team or consult service
No (n = 71) 50 (70.4) 21 (29.6) 0.001 1§ 0.510
Yes (n = 132) 60 (45.5) 72 (54.5) 1.36 (0.55–3.38)
Parents allowed 24 hours a day
No (n = 41) 22 (53.7) 19 (46.3) 0.939 Not Included‡‡
Yes (n = 162) 88 (54.3) 74 (45.7)
Number of beds in the unit (n = 203) 20 (14–29)§§ 18 (13–26)§§ 0.352 Not Included‡‡
Number of medical admissions per year (n = 203) 453 (300–631)§§ 384 (277–600)§§ 0.192 Not Included‡‡
Number of surgical admissions per year (n = 203) 0 (0–30)§§ 20 (0–69)§§ <0.001 1.01 (1.00–1.02) 0.007
Number of ventilator-days per year (n = 203) 312 (115–701)§§ 672 (216–1515)§§ <0.001 1.00 (1.00–1.00) 0.178
NICU = Neonatal intensive care unit.
*Univariate analysis data are for the 203 centres that were included in the multivariable analysis. Other centres were eliminated because of missing data.
†Generalised estimation equation model with country as the cluster.
‡Unless indicated otherwise.
§Reference category.
¶Not included in the model because this variable was highly correlated with local neonatal pain assessment guidelines.
**Locally designated.
††Not included in the model because this variable was highly correlated with the presence of a nurse pain champion.
‡‡Not included in the model because this variable was not significant in univariate analysis.
§§Median (IQR).
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Table 4 Patient characteristics associated with assessments of continuous pain in all neonates
Univariable analysis* Multivariable analysis†
Pain assessment not performed
n = 4354
Pain assessment performed‡
n = 1949 p Value§
Odds ratio
(95% CI) p Value
Sex
Male, number (%), n = 3559 2445 (68.7) 1114 (31.3) 0.449 Not Included¶
Female, number (%), n = 2739 1906 (69.6) 833 (30.4)
Gestational age (weeks)
37–42, number (%), n = 2599 1951 (75.1) 648 (24.9) <0.001 1**
33–36, number (%), n = 1771 1305 (73.7) 466 (26.3) 1.10 (0.94–1.30) 0.232
30–32, number (%), n = 967 559 (57.8) 408 (42.2) 2.11 (1.60–2.80) <0.001
24–29, number (%), n = 966 539 (55.8) 427 (44.2) 1.92 (1.39–2.64) <0.001
Birthweight (grams), n = 6302; Mean (SD) 2505 (991) 2151 (996) <0.001 Not Included††
IUGR
No, number (%), n = 5204 3619 (69.5) 1585 (30.5) 0.083 Not Included¶
Yes, number (%), n = 1093 731 (66.9) 362 (33.1)
Inborn
No, number (%), n = 1137 674 (59.3) 463 (40.7) <0.001 1** 0.023
Yes, number (%), n = 5166 3680 (71.2) 1486 (28.8) 0.67 (0.48–0.95)
Age at admission (hours)
>168, number (%), n = 459 289 (63.0) 170 (37.0) <0.001 1**
73–168, number (%), n = 244 192 (78.7) 52 (21.3) 0.73 (0.48–1.11) 0.143
25–72, number (%), n = 472 345 (73.1) 127 (26.9) 1.09 (0.83–1.43) 0.533
7–24, number (%), n = 709 518 (73.1) 191 (26.9) 0.96 (0.66–1.39) 0.820
<7, number (%), n = 4419 3010 (68.1) 1409 (31.9) 1.22 (0.91–1.63) 0.182
CRIB score‡‡, n = 6303; Median (IQR) 0 (0–1) 1 (0–2) <0.001 0.95 (0.92–0.99) 0.013
Apgar Score at one minute, n = 6284; Median (IQR) 8 (6–9) 7 (5–9) <0.001 Not Included§§
APGAR at five minutes, n = 6303; Median (IQR) 9 (8–10) 9 (7–10) 0.002 1.03 (0.99–1.08) 0.103
Already or immediately intubated at admission
No, number (%), n = 5038 3711 (73.7) 1327 (26.3) <0.001 1** <0.001
Yes, number (%), n = 1265 643 (50.8) 622 (49.2) 1.97 (1.52–2.56)
Surgery
No, number (%), n = 6192 4306 (69.5) 1886 (30.5) <0.001 1** 0.028
Yes, number (%), n = 111 48 (43.2) 63 (56.8) 2.14 (1.09–4.22)
Respiratory distress syndrome
No, number (%), n = 4424 3147 (71.1) 1277 (28.9) <0.001 1** 0.031
Yes, number (%), n = 1879 1207 (64.2) 672 (35.8) 0.77 (0.61–0.98)
Respiratory support¶¶
Spontaneous ventilation, number (%), n = 2862 2302 (80.4) 560 (19.6) <0.001 1**
Noninvasive ventilation, number (%), n = 1448 949 (65.5) 499 (34.5) 1.88 (1.41–2.51) <0.001
Tracheal ventilation, number (%), n = 1993 1103 (55.3) 890 (44.7) 1.29 (0.97–1.70) 0.079
O–SH–GA drugs (continuous and/or bolus)
No, number (%), n = 4503 3381 (75.1) 1122 (24.9) <0.001 1** <0.001
Yes, number (%), n = 1800 973 (54.1) 827 (45.9) 1.99 (1.55–2.54)
Length of NICU stay (days)***, n = 6303; Median (IQR) 8 (3–18) 9 (4–24) <0.001 0.99 (0.97–1.00) 0.074
NICU = Neonatal intensive care unit; O–SH–GA = Opioids, sedatives/hypnotics, or general anaesthetics; IUGR = Intrauterine growth retardation; CRIB = Clinical
Risk Index for Babies; CI = Confidence interval; SD = Standard deviation; IQR = Interquartile range.
*Univariable analysis data for 6303 neonates that were included in the multivariable analysis.
†Generalised estimating equations model with NICU as cluster.
‡At least one continuous pain assessment during the entire NICU stay.
§Comparisons were made with chi-square tests (Fisher’s exact test when required), t-tests or Mann–Whitney tests as appropriate.
¶Not included in the model because this variable was not significant in univariate analysis.
**Reference category.
††Not included in the model because this variable was highly correlated with gestational age.
‡‡Odds ratio per point increase in CRIB score. The CRIB score is a measure of illness severity in neonates. It consists of six items collected in the first 12 hours after
birth (range: 0–23, higher scores indicate great clinical risk of mortality).
§§Not included in the model because this variable was highly correlated with Apgar scores at five minutes.
¶¶Patients were classified in three groups according to the highest level of ventilation they received during the study period.
***Data collection was stopped on day 28 of hospital stay; 989 (15.7%) of 6303 neonates were hospitalised for longer than 28 days.
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Lindgren’s Children’s Hospital Pain Scale) (23) and the
Neonatal Pain, Agitation and Sedation Scale (N-PASS) (42)
were designed to assess continuous pain. To develop the
EDIN scale, a panel of experts assessed video recordings of
neonates with prolonged pain (e.g. necrotising enterocolitis,
postoperative pain) for behavioural indicators of pain (facial
activity, body movements, quality of sleep, quality of contact
with nurses, consolability). It showed acceptable inter-rater
reliability, high internal consistency and significant differ-
ences between painful and nonpainful conditions, suggesting
preliminary construct validity (22). van Dijk et al. adapted
COMFORT scale to develop the COMFORTneo scale for
newborns with prolonged pain, which appeared to be a
promising tool but requires additional studies to support its
validity and clinical utility (24). Similarly, Lundqvist et al.
adapted the ALPS-1 scale to develop the ALPS-Neo using
five behavioural parameters, including facial expressions,
breathing pattern, limb muscle tone, hand/foot activity and
level of activity to assess continuous pain in neonates (23).
They reported acceptable reliability and face validity,
although this tool also requires further validation (23). The
N-PASSwasdesigned toassess painand sedation inneonates
with postoperative pain or mechanical ventilation and
showed adequate inter-rater reliability, convergent and
discriminate validity (42), and clinical utility (43). It was
later applied to acute pain with similar results (44). Despite
the availability of these scales, continuous pain lacks a
consistent definition.
Pillai-Riddell et al. (16) interviewed experienced clini-
cians to define chronic pain in infancy. Their qualitative
analysis suggested that inability to settle, social withdrawal,
constant grimacing, tense body, hypo- or hyper-reactivity to
acute pain, dysregulated sleep or feeding patterns could serve
as potential indicators for chronic pain. Secondary analyses
from the NEOPAIN trial suggested that facial expressions of
pain, high activity levels, poor response to handling and poor
ventilator synchronicity were most frequently associated
with continuous pain in preterm newborns ≤32 weeks of
gestation (15). Although both studies found some overlap
with EDIN parameters, they were not used to develop novel
assessment tools for persistent pain in neonates.
Although the PIPP and CRIES scales have been tested in
settings of postoperative pain, their construct validity as tools
to assess continuous pain remains unproven (25,45). Our
finding of infrequent assessments of continuous pain is not
surprising in the context of few assessment tools available
and relative lack of across-the-board validity data for these
methods (18,41). Furthermore, the validity of these scales
when translated into the different languages spoken in the
participating countries has not been established.
Meaning of the study
Infrequent and highly variable assessments of continuous
pain in newborns may contribute to analgesic complications
(46), oversedation (47) or tolerance/withdrawal (48). Given
the limitations and controversies reviewed above, the vari-
ability noted in this study is not unexpected and mirrors
similar findings in adult patients (49). Our data show that
local NICU guidelines and local nurse champions substan-
tially increased the odds for pain assessment, whereas the
availability of pain consult services did not (Table 3). All
NICUs shoulddevelop standardised approaches for neonatal
pain and identify experienced nurses to lead this effort. Most
NICUs had local neonatal pain guidelines, but only a third of
the participating countries had national guidelines. Policy-
makers at the EuropeanMedicines Agency and/or European
professional societies should consider developing neonatal
pain guidelines for NICUs in all European countries.
Figure 2 Frequency of assessments of continuous pain in the tracheal ventilation (TrV) group on patient-days with or without TrV, or with or without the use of O-SH-
GA drugs. Data from all ventilated neonates (n = 2138) were analysed for the 33 625 patient-days of observation. p Values are based on chi-square tests.
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Table 5 Patient characteristics associated with assessments of continuous pain assessments in tracheally ventilated newborns
Univariable analysis* Multivariable analysis†
Pain assessment
not performed
n = 1104
Pain assessment
performed‡
n = 890 p Value§ Odds ratio (95% CI) p Value
Sex
Male, number (%), n = 1174 642 (54.7) 532 (45.3) 0.428 Not Included¶
Female, number (%), n = 818 462 (56.5) 356 (43.5)
Gestational age (weeks)
37–42, number (%), n = 571 322 (56.4) 249 (43.6) 0.077 Not Included¶
33–36, number (%), n = 372 224 (60.2) 148 (39.8)
30–32, number (%), n = 338 186 (55.0) 152 (45.0)
24–29, number (%), n = 712 371 (52.1) 341 (47.9)
Birthweight (grams), n = 1994; Mean (SD) 2002 (1042) 1920 (1022) 0.079 Not Included¶
IUGR
No, number (%), n = 1669 925 (55.4) 744 (44.6) 0.962 Not Included¶
Yes, number (%), n = 322 178 (55.3) 144 (44.7)
Inborn
No, number (%), n = 588 284 (48.3) 304 (51.7) <0.001 1** 0.297
Yes, number (%), n = 1406 820 (58.3) 586 (41.7) 0.83 (0.59–1.18)
Age at admission (hours)
>168, number (%), n = 172 84 (48.8) 88 (51.2) 0.064 Not Included¶
73–168, number (%), n = 45 27 (60.0) 18 (40.0)
25–72, number (%), n = 88 42 (47.7) 46 (52.3)
7–24, number (%), n = 214 109 (50.9) 105 (49.1)
<7, number (%), n = 1475 842 (57.1) 633 (42.9)
CRIB score††, n = 1994; Mean (SD) 3.4 (3.7) 3.0 (3.1) 0.015 0.93 (0.90–0.97) 0.001
APGAR at one minute, n = 1989; Median (IQR) 6 (4–8) 6 (3–8) 0.431 Not Included¶
APGAR at five minutes, n = 1994; Median (IQR) 8 (6–9) 8 (6–9) 0.020 1.04 (0.99–1.09) 0.119
Already or immediately intubated at admission
No, number (%), n = 729 461 (63.2) 268 (36.8) 0.001 1** <0.001
Yes, number (%), n = 1265 643 (50.8) 622 (49.2) 2.00 (1.55–2.58)
Surgery
No, number (%), n = 1910 1069 (56.0) 841 (44.0) 0.010 1** 0.256
Yes, number (%), n = 84 35 (41.7) 49 (58.3) 1.53 (0.73–3.18)
Respiratory distress syndrome
No, number (%), n = 1020 538 (52.7) 482 (47.3) 0.016 1** 0.155
Yes, number (%), n = 974 566 (58.1) 408 (41.9) 0.83 (0.64–1.07)
O-SH-GA drugs (continuous and/or bolus)
No, number (%), n = 438 264 (60.3) 174 (39.7) 0.019 1** 0.008
Yes, number (%), n = 1556 840 (54.0) 716 (46.0) 1.45 (1.10–1.92)
Length of stay in NICU (days)‡‡, n = 1994; Median (IQR) 15 (6–28) 14 (6–28) 0.590 Not Included¶
Total duration of mechanical ventilation (hours), n = 1994; Median (IQR) 37 (11–112) 61 (20–142) <0.001 1.00 (1.00–1.00) 0.001
Number of ventilator-free days§§, n = 1994; Median (IQR) 23 (8–26) 23 (14–26) 0.777 Not Included¶
NICU = Neonatal intensive care unit; O–SH–GA = Opioids, sedatives/hypnotics or general anaesthetics; IUGR = Intrauterine growth retardation; CRIB = Clinical
Risk Index for Babies; CI = Confidence interval; SD = Standard deviation; IQR = Interquartile range.
*Univariable analysis data for the 1994 neonates that were included in the multivariable analysis.
†Generalised estimation equation model with NICU as cluster.
‡At least one assessment of continuous pain during the NICU stay.
§Comparisons were made with chi-square tests (Fisher’s exact test when required), t-tests or Mann–Whitney tests as appropriate.
¶Not included in the model because this variable was not significant in the univariable analysis.
**Reference category.
††Odds ratio per point increase in CRIB score. The CRIB score is a measure of illness severity in neonates. It consists of six items collected in the first 12 hours after
birth (range: 0–23, higher scores indicate great clinical risk of mortality).
‡‡Data collection was stopped on day 28 of hospital stay: 566 (28.4%) of 1994 neonates were hospitalised for longer than 28 days.
§§Ventilator-free days were defined as the number of calendar days from the time of tracheal extubation to day 28 after NICU admission. If a neonate was
reintubated and subsequently extubated before day 28, ventilator-free days were counted from the end of the last period of tracheal intubation. If a neonate was
still receiving tracheal ventilation on day 28 or had died before day 28, then 0 ventilator-free days were noted. For neonates discharged before day 28 of
admission, ventilator-free days were zero if the neonate was still intubated at discharge (transfer) and ventilator-free days were counted from the time of tracheal
extubation to day 28 after NICU admission if the neonate was already extubated at discharge.
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Unanswered questions and future research
Neonatal pain research has been focused on the acute
episodic pain associated with skin-breaking procedures
(4,11,12,36,37,50). We suggest the need for a paradigm shift
in neonatal pain research, paying greater attention to
prolonged or continuous pain in newborns. First, we need
to reach consensus on the taxonomy and definitions of
various pain terms applied to neonates. Achieving consensus
on these terms may lead to developing newer assessment
tools, examining the validity and clinical utility of currently
available and novel methods, and using these methods to
determine the need for, and the efficacy of therapeutic
approaches treating continuous pain in neonates. Neuro-
physiological approaches (51) such as near-infrared spec-
troscopy, electroencephalography or functional MRI can
displaypain-inducedactivity in thebrain (2,52),whereas skin
conductance, heart rate variability or pupillometry candetect
autonomic activity in neonates (41,53). If these approaches
lead to reliable and clinically useful pain measures, they may
allow an independent validation of observer-dependent pain
assessment scales for both episodic and continuous pain.
Recent guidelines from American Academy of Pediatrics
state that validated pain assessment tools should be used
consistently to initiate and monitor the effectiveness of
analgesic interventions (30). Reliable and objective mea-
sures of continuous pain in newborns must be defined,
developed, extensively validated and used regularly at the
bedside, to improve the safety and efficacy of analgesics or
other therapies used for treating neonatal pain. By avoiding
the acute and long-term effects of both unrelieved pain and
unnecessary analgesia in newborns, we can optimise seda-
tion/analgesia, improve clinical outcomes and reduce pain-
related suffering in newborns.
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